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OBJECTIVE: Obstructive jaundice develops after occlusion of the common bile duct. Direct hyperbiliru-
binaemia, which occurs secondary to the condition, causes various life-threatening pathologies.
Cytoprotective effects of Ganoderma lucidum (GL) have previously been shown. In this study, the effects of
GL on oxidative stress and oxidant DNA damage in experimental obstructive jaundice were evaluated.
METHODS: Sixty Wistar albino adult female rats were randomly divided into six weight-matched equal
groups: sham group, bile duct ligated group (BDL); after sham operation 250 mg/kg/d of GL administered
group, after sham operation 500 mg/kg/d of GL administered group, after bile duct ligation 250 mg/kg/d
of GL administered (GL1BDL) group, and after bile duct ligation 500 mg/kg/d of GL administered
(GL2BDL) group. GL polysaccharide was orally administered to the rats via gavage tube once a day for 
14 days after bile duct ligation.
RESULTS: The plasma malondialdehyde levels of the GL1BDL and GL2BDL groups were significantly
lower than those of the BDL group (p < 0.01). The plasma 8-hydroxy-2′-deoxyguanosine levels of the
GL1BDL and GL2BDL groups were significantly lower than those of the BDL group (p < 0.001). The liver
tissue Cu-Zn superoxide dismutase level of the GL2BDL group was significantly higher than that of the
BDL group (p < 0.05).
CONCLUSION: GL protected against DNA and liver tissue damage by reducing oxidative stress in
obstructive jaundice. [Asian J Surg 2010;33(4):173–80]
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Introduction
Obstructive jaundice (OJ) develops after occlusion of the
common bile duct as a result of benign or malignant dis-
eases such as choledocholithiasis, bile duct strictures, or
cholangiocarcinoma.1 Direct hyperbilirubinaemia, which
occurs secondary to OJ, causes liver dysfunction, gastroin-
testinal barrier dysfunction, immune dysfunction, coagu-
lation dysfunction, lack of detoxification, and diminished
wound healing.2 Icteric conditions ameliorate the harm-
ful oxidant molecular modifications that causing life-
threatening conditions.3,4
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Reactive oxygen species (ROS), namely superoxide and
hydroxyl free radicals, together with hydrogen peroxide,
are believed to be directly toxic, and ROS can initiate free-
radical-mediated chain reactions.5 ROS damage the build-
ing structures of the cell membrane, nucleus, and genetic
meterial by causing scission, carbonylation, fragmentation,
cross-linking, and oxidation. These structural changes lead
to the decrease or loss of protein biological function.6,7
Malondialdehyde (MDA) is one of the products of lipid per-
oxidation.8 The compound 8-hydroxy-2′-deoxyguanosine
(8-OHdG) is an oxidant of deoxyguanosine and a marker for
oxidative DNA damage.9 Oxidant and antioxidant statuses
are vital for regulation of homeostasis. Glutathione (GSH)
and superoxide dismutase (SOD) are involved in the antiox-
idant system and are important for the protection of tissue
from oxidative damage. GSH is a tripeptide. Its oxidized
form, the dimer GSSG, which is involved in the transport of
certain amino acids, is a coenzyme for various enzymes and
protects against oxygen radicals and toxic compounds.
GSH removes toxic substances from the environment and
protects tissue from harmful substances after biotransfor-
mation. SOD, which catalyzes the dismutation of super-
oxide to hydrogen peroxide, catalyzes the conversion of
two O2 molecules into H2O2 and O2. SOD exists in mito-
chondrial (Mn-SOD) and cytoplasmic (Cu/Zn-SOD)
forms.10,11 Oxidative stress is also involved in the regulation
of almost all cellular processes, including proliferation, dif-
ferentiation, stress responses, and cell death.6,7,11
Ganoderma lucidum (GL) is a crude drug used in Chinese
medicine for the treatment of fatigue, insomnia, cough in
elderly people, and some types of cancer.12 GL peptides are
strong antioxidants and have potent free radical-scavenging
activities.13 GL showed protective actions against acute hep-
atitis in some experimental studies.14,15 However, there is
no data about the effects of GL therapy on oxidative stress
in OJ. In this study, the effects of GL on oxidative stress and
oxidative DNA damage in experimental OJ were evaluated.
Patients and methods
This study was performed with approval from the Ethics
Committee of the Animal Care Review Board of Istanbul
University Experimental Medicine Research Institute. Adult
female Wistar albino rats weighing 200–250g were ob-
tained from the Experimental Animal Research Laboratory
of Cerrahpasa Medical Faculty. The animals were housed
in cages in a regulated environment (23 ± 2°C and 55 ± 15%
relative humidity) under a 12-hour light/dark cycle and per-
mitted ad libitum access to standard lab chow and tap water
before and after surgery. The experiment was performed in
the Cerrahpasa Medical Faculty Experimental Animal
Research Laboratory. Sixty rats were randomly divided into
six weight-matched equal groups. Group 1: sham group;
Group 2: bile duct ligated group (BDL); Group 3: after sham
operation GL (250 mg/kg/d) administered (GL1) group;
Group 4: after sham operation GL (500 mg/kg/d) adminis-
tered (GL2) group; Group 5: after bile duct ligation GL
(250 mg/kg/d) administered (GLBDL1) group; and Group
6: after bile duct ligation GL (500 mg/kg/d) administered
(GL2BDL) group. GL polysaccharide (Ling Zhi extract) was
purchased from Khao-La-Or Laboratories Ltd. (Samut
Prakan, Thailand). GL polysaccharide was diluted with
saline solution at daily doses of 250 mg/kg and 500 mg/kg
as an aqueous extract. GL polysaccharide was orally admin-
istered to the rats via gavage tube once a day for 14 days
after bile duct ligation. The sham operated groups and the
BDL group received equal amounts of saline solution. The
rats were sacrificed on postoperative day 14 by cervical dis-
location, and blood and the tissue samples were collected.
Surgical procedure
Under ketamine (40 mg/kg, intraperitoneal) and xylazine
(5 mg/kg, intramuscular) anaesthesia, through a midline
abdominal incision, the common bile duct was isolated and
double-ligated in its middle third with 0000 silk suture; it
was then transected between the two ligatures. In the
sham operation, the common bile duct was isolated with-
out ligation or transection after a midline abdominal inci-
sion. The abdomen was closed with continuous sutures.
Biochemical procedures
Preparation of the tissue samples
Approximately 190–200 mg of each liver sample was
weighed and diluted 20% weight per volume in 20 mM ice-
cold Tris-HCl, pH 7.4, and homogenized with a homogeni-
zator (Bosch Scintilla, SA, Switzerland). The homogenate
was centrifuged at 5000g for 10 minutes, and various analyte
determinations were performed in the supernatant fraction.
Assay of protein carbonyl
Plasma and tissue protein carbonyl levels were measured
spectrophotometrically using the method of Reznick 
and Packer.16 Protein carbonyl groups react with 2,4-
dinitrophenylhydrazine (DNPH) to generate chromophoric
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dinitrophenylhydrazones. DNPH was dissolved in HCl, and
following the DNPH reaction, proteins were precipitated
with an equal volume of 20% trichloroacetic acid (w/v) and
washed three times with 4 mL of an ethanol/ethyl acetate
mixture (1:1). Washings were performed by mechanical dis-
ruption of pellets in the washing solution using a small
spatula and repelleting by centrifugation at 6000g for 
5 minutes. Finally, the precipitates were dissolved in a 6-M
guanidine-HCl solution, and the absorbances were mea-
sured at 360 nm using the molar extinction coefficient of
DNPH (e = 2.2 × 104/M·cm). The protein content was spec-
trophotometrically determined on the HCl blank pellets
using a Folin kit (Sigma Diagnostics, St. Louis, MO, USA).
The coefficients of intra-assay and interassay variations
for the carbonyl assay were 4.1% and 8.5%, respectively.
Assay of malondialdehyde
Lipid peroxidation levels in plasma and tissue were mea-
sured with the thiobarbituric acid reaction.17 This method
was used to obtain a spectrophotometric measurement of
the colour produced during the reaction to thiobarbituric
acid with MDA at 535 nm. The coefficients of intra- and
interassay variations for the MDA assay were 3.6% and
5.3%, respectively.
Assay of total thiol content
Plasma and tissue thiol concentrations were determined
using 5,5′-dithio-bis(2-nitrobenzoic acid) as described by
Hu.18 The coefficients of intra-assay and interassay varia-
tions were 2.2% and 4.9%, respectively.
Assay of glutathione
GSH concentrations were determined according to the
method of Beutler et al19 using metaphosphoric acid for
protein precipitation and 5,5′-dithio-bis (2-nitrobenzoic
acid) for colour development.
Assay of Cu-Zn SOD activity
Plasma and tissue Cu-Zn SOD activity was determined by
the method of Sun et al.20 The assay involved inhibition
of nitroblue tetrazolium (Sigma Chemical Co., St. Louis,
MO, USA) and reduction with xanthine-xanthine oxidase
(Sigma Chemical Co.), which is used as a superoxide gener-
ator. One unit of SOD is defined as the amount of protein
that inhibits the nitroblue tetrazolium reduction rate by
50%. The coefficients of intra-assay and interassay varia-
tions were 1.8% and 3.2%, respectively.
Assay of 8-OHdG
The plasma 8-OHdG levels were determined using an
enzyme-linked immunosorbent assay detection kit
(Bioxytech 8-OHdG-EIA; OXIS Health Products, Portland,
OR, USA). The coefficients of intra-assay and interassay
variations for the 8-OHdG assay were 6.4% and 7.4%,
respectively.
Histopathological evaluation
Liver biopsies obtained from the same lobe were fixed
overnight in 10% buffered formalin and paraffin-embedded.
The sections were stained with haematoxylin and eosin
(H&E) for histological evaluation and examined under a
light microscope. In brief, 4-μm-thick sections of paraffin-
embedded rat liver were dewaxed in xylene, rehydrated in
graded alcohol series, and washed with distilled water for
2 minutes. The sections were then stained with haema-
toxylin for 5 minutes at room temperature. After 15 min-
utes, the sections were counterstained with eosin for 
2 minutes, dehydrated in graded alcohol series, washed
with xylene, and blocked by rosin.
H&E-stained slides were evaluated under a microscope
at 40× magnification by an experienced pathologist
(Figure 1). The pathologist did not know which specimen
belonged to which group. A method similar to that of
Lichtman et al21 was used to score liver histology. Pa-
renchymal injury (cell lining, regenerative activity, hepato-
cyte necrosis, deposition of bile pigments, hydropic
degeneration, and polymorphonuclear cell infiltration),
sinusoid injury (ductal proliferation, sinusoidal thrombosis,
and Kupffer cell proliferation), and portal area injury (duc-
tal proliferation, cholangitis, acute inflammation, chronic
inflammation, bile retention, portal vascular congestion,
and portal vascular thrombosis) were numbered from 0 to
3 (0 = none, 1 = slight, 2 = moderate, and 3 = severe). Fibrosis
was graded according to the previously described method:
Grade 0 = normal liver; Grade 1 = increase in collagen with-
out formation of septa; Grade 2 = formation of incom-
plete septa from portal tract to central vein (septa that do
not interconnect with each other); Grade 3 = complete but
thin septa interconnecting with each other, dividing the
parenchyma into separate fragments; and Grade 4 = as
Grade 3, but with thick septa (complete cirrhosis).22
Statistical analysis
All data are expressed as means and SD and 95% confi-
dence intervals. For biochemical parameters, one-way
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analysis of variance and Tukey’s post hoc test were used for
statistical analysis and p < 0.05 was considered significant.
For histological parameters, the Bonferroni-adjusted
Mann-Whitney test was used for statistical analysis and
p < 0.0083 was considered significant.
Results
The results are summarized in Tables 1 and 2. No rats
died during the experimental procedure. Bilirubin levels
of the BDL, GL1BDL, and GL2BDL groups were signifi-
cantly higher than those of the sham group (p < 0.001).
There were no significant differences between the sham,
GL1, and GL2 groups in the bilirubin levels. The oxidative
stress parameters of the BDL group were significantly
higher than those of the sham group (p < 0.05). The plasma
MDA, 8-OHdG, and protein carbonyl levels of the BDL
group were significantly higher than those of the sham
group (p < 0.001). The plasma Cu-Zn SOD, thiol, and
GSH levels of the BDL group were significantly lower
than those of the sham group (p < 0.001). There were no
differences between the GL1, GL2, and sham groups in
the plasma oxidative stress parameters. The plasma MDA
levels of the GL1BDL and GL2BDL groups were signifi-
cantly lower than those of the BDL group (p < 0.01)
(Figure 2). The plasma 8-OHdG levels of the GL1BDL and
GL2BDL groups were significantly lower than those of
the BDL group (p < 0.001) (Figure 3). The plasma protein
carbonyl level of the GL2BDL group was significantly
lower than that of the BDL group (p < 0.01).
The liver tissue thiol, GSH, and Cu-Zn SOD levels of
the BDL group were significantly lower than those of the
sham group (p < 0.01). The values of the parameters in the
liver tissue of the GL1 and GL2 groups were similar 
to those of the sham group. The liver tissue Cu-Zn SOD
level of the GL2BDL group was significantly higher than
that of the BDL group (p < 0.05). The liver tissue protein
carbonyl levels of the GL1BDL and GL2BDL groups were
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Figure 1. (A) Histology of the bile duct ligated group where confluent necrosis, sinusoidal inflammation, cholangitis, and inflamma-
tion in the portal area are seen. (B) Histology of the sham group where normal liver tissue structure is seen, (C) after bile duct liga-
tion Ganoderma lucidum (GL; 250 mg/kg/d) administered group (GL1BDL) and (D) after bile duct ligation GL (500 mg/kg/d)
administered group (GL2BDL) where reduced necrosis is seen.
■ GANODERMA LUCIDUM TREATMENT IN OBSTRUCTIVE JAUNDICE ■
ASIAN JOURNAL OF SURGERY VOL 33 • NO 4 • OCTOBER 2010 177
Table 1. Plasma levels of the biochemical parameters
Cu-Zn SOD MDA 8-OHdG PCO Thiol GSH Total Bilirubin
(U/mL) (nmol/mL) (ng/mL) (nM/mg) (μM/mg) (mg/gHb) (mg/dL)
Sham 24.71 ± 2.26 2.98 ± 0.27 5.81 ± 0.99 0.73 ± 0.2 319.56 ± 20.31 4.04 ± 0.21 0.18 ± 0.09
BDL 18.46 ± 1.57* 4.65 ± 0.47* 11.23 ± 0.95* 1.19 ± 0.2* 246.73 ± 22.4* 2.88 ± 0.14* 9.48 ± 0.2*
GL1 24.73 ± 3.16 2.70 ± 0.18 5.57 ± 1 0.73 ± 0.11 300.44 ± 23.25 3.76 ± 0.34 0.19 ± 0.07
GL2 23.12 ± 3.1 2.76 ± 0.25 5.41 ± 1.04 0.72 ± 0.12 329.25 ± 20.74 4 ± 0.3 0.17 ± 0.1
GL1BDL 19.99 ± 1.41* 3.92 ± 0.46*† 6.88 ± 1.09‡ 1.03 ± 0.16* 253 ± 22.86* 2.99 ± 0.41* 9.03 ± 0.79*
GL2BDL 21.21 ± 1.59§ 3.92 ± 0.45*† 7.13 ± 0.85‡ 0.92 ± 0.12†§ 269.38 ± 19.74* 3.24 ± 0.26* 9.28 ± 0.38*
*p < 0.001 between the sham group and the other groups; †p < 0.01 between the BDL group and the other groups; ‡p < 0.001 between 
the BDL group and the other groups; §p < 0.05 between the sham group and the other groups. BDL = bile duct ligated group; GL1 = after
sham operation Ganoderma lucidum (GL; 250 mg/kg/d) administered group; GL2 = after sham operation GL (500 mg/kg/d) administered
group; GLBDL1 = after bile duct ligation GL (250 mg/kg/d) administered group; GL2BDL = after bile duct ligation GL (500 mg/kg/d) admin-
istered group; SOD = superoxide dismutase; MDA = malondialdehyde; 8-OHdG = 8-hydroxy-2′-deoxyguanosine; PCO = protein carbonyl;
GSH = glutathione.
Table 2. Liver tissue levels of the biochemical parameters
Cu-Zn SOD MDA PCO Thiol GSH
(U/mg) (nmol/mg) (nmol/mg) (nmol/mg) (nmol/mg)
Sham 0.62 ± 0.11 0.93 ± 0.19 0.22 ± 0.03 109.22 ± 12.59 31.33 ± 2.6
BDL 0.35 ± 0.09* 1.47 ± 0.16 0.72 ± 0.11* 83.6 ± 9.31† 23 ± 3.16*
GL1 0.63 ± 0.07 0.9 ± 0.18 0.21 ± 0.07 100 ± 15.05 29.44 ± 2.5
GL2 0.66 ± 0.11 0.83 ± 0.19 0.2 ± 0.05 115 ± 14.2 31.13 ± 2.26
GL1BDL 0.45 ± 0.06† 1.12 ± 0.14 0.5 ± 0.07*‡ 88.67 ± 8.31† 24.67 ± 3.5*
GL2BDL 0.5 ± 0.04§ 1.35 ± 0.9 0.38 ± 0.11*‡ 93.25 ± 15.87 26.63 ± 3.35
*p < 0.001 between the sham group and other groups; †p < 0.01 between the sham group and other groups; ‡p < 0.001 between the BDL
groups and the other groups; §p < 0.05 between the BDL group and the other groups; p < 0.05 between the sham and the other groups.
BDL = Bile duct ligated group; GL1 = after sham operation Ganoderma lucidum (GL; 250 mg/kg/d) administered group; GL2 = after sham oper-
ation GL (500 mg/kg/d) administered group; GLBDL1 = after bile duct ligation GL (250 mg/kg/d) administered group; GL2BDL = after bile
duct ligation GL (500 mg/kg/d) administered group; SOD = superoxide dismutase; MDA = malondialdehyde; PCO = protein carbonyl;
GSH = glutathione.
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Figure 2. The plasma malondialdehyde (MDA) levels of the
GL1BDL and GL2BDL groups were significantly lower than those
of the BDL group. *p < 0.01. GLBDL1 = after bile duct ligation
Ganoderma lucidum (GL; 250 mg/kg/d) administered group;
GL2BDL = after bile duct ligation GL (500 mg/kg/d) adminis-
tered group; BDL = bile duct ligated group.
Figure 3. The plasma 8-hydroxy-2′-deoxyguanosine (8-OHdG)
levels of the GL1BDL and GL2BDL groups were significantly
lower than those of the BDL group. *p < 0.001. GLBDL1 = after
bile duct ligation Ganoderma lucidum (GL; 250 mg/kg/d) adminis-
tered group; GL2BDL = after bile duct ligation GL (500 mg/kg/d)
administered group; BDL = bile duct ligated group.
significantly lower than those of the BDL group (p < 0.001)
(Figure 4).
In the histological evaluation (Table 3), the cell lining,
hepatocyte necrosis, deposition of bile pigments, hydropic
degeneration, polymorphonuclear cell infiltration, ductal
proliferation, sinusoidal thrombosis, Kupffer cell prolifer-
ation, cholangitis, acute inflammation, chronic inflam-
mation, bile retention, portal vascular congestion, portal
vascular thrombosis, and fibrosis scores of the BDL group
were significantly higher than those of the sham group
(p < 0.000). There were no significant histological differ-
ences between the sham, GL1, and GL2 groups. Lower duc-
tal proliferation and sinusoidal thrombosis scores were
observed in both the GL1BDL (p < 0.001) and GL2BDL
(p < 0.007) groups according to the BDL group. Kupffer cell
proliferation (p < 0.002), cholangitis (p < 0.001), acute in-
flammation (p < 0.000), chronic inflammation (p < 0.004),
and bile retention (p < 0.002) scores of the GL1BDL group
were significantly lower than those of the BDL group.
Discussion
Decompression with surgery or minimally invasive tech-
niques is the principle treatment of OJ in clinical practice.
However, sometimes these interventional therapies are not
sufficient to prevent the development of life-threatening
complications of hyperbilirubinaemia.23,24 In previous
experimental studies, it has been shown that bile duct
obstruction induces oxidative stress and reduces the pro-
duction of different enzymes with antioxidant properties.
Additionally, increased lipid peroxidation is observed in
patients with cholestatic liver disease.25,26 Increased levels
of MDA result in oxidative damage to lipids, and
increased levels of protein carbonyl is a marker of oxida-
tive protein modification.27,28 Decreased GSH levels
caused by impaired biliary secretion are seen in prolonged
cholestatic liver diseases.23 Augmented oxidant activity
that is mediated by ROS damages DNA.29 We observed
the harmful effect of OJ on the biochemical and histolog-
ical parameters in the plasma and liver tissue. The level of
MDA did not change in the cholestatic liver tissue, but a
significant upswing of lipid peroxidation was seen in the
plasma. Increased protein oxidation and depleted antioxi-
dant activity were the biochemical evidence of oxidant dam-
age in the liver tissue after bile duct ligation. In our opinion,
the uncorrelated liver tissue and plasma MDA levels have
two possible explanations. First, hyperbilirubinaemia is 
a systemic pathology and could cause additional oxidant
damage to other organs, and the rank of the oxidized lipid
molecules could be higher in plasma according to liver tis-
sue. Second, protein oxidation could occur before lipid per-
oxidation in hyperbilirubinaemic conditions.
The effects of many different chemicals on oxidative
stress were evaluated in experimental OJ. Recently, the ame-
liorative effects of methylene blue, fluvastatin, and sphin-
gosylphosphorylcholine against cholestatic liver injury via
their antioxidant and anti-inflammatory actions have been
documented.3,4,30 We did not observe any toxic effects of
GL, which is a popular mushroom-derived drug of tradi-
tional Chinese medicine.12 As a consequence of GL therapy,
DNA damage and oxidative stress parameters of plasma
were reduced in OJ. Histological findings showed that GL
treatment ameliorated the harmful effects of hyperbilirubi-
naemia. Reduced bile retention and reduced inflammation
were noticed in the liver tissue of the GL-treated, OJ-
induced groups. GL could be cytoprotective via suppression
of damaging factors and support of cell proliferation.31
Beneficial effects of GL were shown in acute and chronic
hepatic inflammation induced by BCG-immunostimuli in
mice.15 Triterpene extract of GL inhibits NF-kappa B and
AP-1 signalling pathways, which are main mediators of the
inflammatory response.32 Although the active components
responsible for the antioxidant activity of GL are still not
well documented, the efficacious effects of GL via its anti-
oxidant properties have been presented.12,13 GL resulted
in reduced liver fibrosis induced by CCl4. Lin and 
Lin33 suggested that oral administration of GL could
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Figure 4. Liver tissue protein carbonyl (PCO) levels of the
GL1BDL and GL2BDL groups were significantly lower than those
of the BDL group. *p < 0.001. GLBDL1 = after bile duct ligation
Ganoderma lucidum (GL; 250 mg/kg/d) administered group;
GL2BDL = after bile duct ligation GL (500 mg/kg/d) adminis-
tered group; BDL = bile duct ligated group.
reduce chronic liver injury via a protective effect against
hepatocellular necrosis by its free-radical scavenging abil-
ity. Park et al34 reported that the polysaccharide of GL
reduced serum aspartate transaminase, alanine transami-
nase, alkaline phosphatase, and total bilirubin; reduced
the collagen content in liver; and improved liver morphol-
ogy. They claimed that GL polysaccharides could act as
antifibrotic agents. Wu et al35 suggested that GL extracts
enhance collagenolytic activity. We noticed increased
fibrosis on the cholestatic liver histology, but no fibrolytic
activity of GL was observed among the experimental
groups. The discrepancy of the results of the studies
could be related to the duration and design of the experi-
mental procedures, sequence and dosage of the GL
administration, and type of experimental animal. Further
analysis must be performed to evaluate the activity of GL
against liver fibrosis. In our study, increased total bilirubin
levels were not changed after GL treatment because the
rats underwent an acute, mechanical, total, and unrelieved
biliary obstruction lasting throughout the study period, as
previously described.36
In conclusion, GL has antioxidant activity in direct
hyperbilirubinaemic conditions and may protect DNA
structure and liver tissue by reducing oxidative damage in
OJ as a palliative agent. However, further studies are
needed to clarify the protective mechanisms of GL.
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Table 3. Scores of the histological evaluation
Parameters Sham BDL GL1 GL2 GL1BDL GL2BDL
Cell lining 0 2.4 ± 0.52* 0.5 ± 0.53 0.5 ± 0.53 2.5 ± 0.53 2.7 ± 0.48
Regenerative activity 0.2 ± 0.42 1.3 ± 0.67 0.3 ± 0.48 0.4 ± 0.52 1.4 ± 0.52 1.6 ± 0.52
Hepatocyte necrosis 0 2.4 ± 0.53* 0.1 ± 0.32 0 2.1 ± 0.32 2.3 ± 0.48
Deposition of bile pigments 0.1 ± 0.32 2.6 ± 0.52* 0.2 ± 0.42 0.2 ± 0.42 2.4 ± 0.52 2.4 ± 0.52
Hydropic degeneration 0 2.1 ± 0.32* 0 0.1 ± 0.32 1.9 ± 0.57 2 ± 0.67
Polymorphonuclear 0.1 ± 0.32 2.7 ± 0.48* 0.3 ± 0.48 0.4 ± 0.52 2.6 ± 0.52 2.5 ± 0.53
cell infiltration
Ductal proliferation 0.1 ± 0.32 1.9 ± 0.32* 0.3 ± 0.48 0.2 ± 0.42 0.9 ± 0.57† 0.8 ± 0.63†
p < 0.001 p < 0.007
Sinusoidal thrombosis 0 2.2 ± 0.42* 0.2 ± 0.42 0.2 ± 0.42 1 ± 0.47† 0.8 ± 0.42†
p < 0.000 p < 0.000
Kupffer cell proliferation 0.1 ± 0.32 2.6 ± 0.52* 0.7 ± 0.48 0.2 ± 0.63 1.5 ± 0.53† 2.5 ± 0.89
p < 0.002
Cholangitis 0.2 ± 0.42 2.7 ± 0.48* 0.2 ± 0.42 0.2 ± 0.42 1.4 ± 0.7† 2.4 ± 0.52
p < 0.002
Acute inflammation 0.1 ± 0.32 2.8 ± 0.42* 0.2 ± 0.63 0.3 ± 0.48 1.2 ± 0.92† 2.5 ± 0.53
p < 0.000
Chronic inflammation 0.2 ± 0.63 2.3 ± 0.67* 0.3 ± 0.48 0.2 ± 0.42 1.2 ± 0.63† 2.4 ± 0.84
p < 0.004
Bile retention 0.1 ± 0.32 2.3 ± 0.82* 0.1 ± 0.32 0.3 ± 0.48 0.9 ± 0.57† 2.1 ± 0.88
p < 0.002
Portal vascular congestion 0.1 ± 0.32 2.3 ± 0.82* 0.2 ± 0.42 0.1 ± 0.32 1.6 ± 0.52 2.1 ± 0.74
Portal vascular thrombosis 0.1 ± 0.32 1.3 ± 0.67* 0.3 ± 0.48 0.2 ± 0.42 1.6 ± 0.7 1.2 ± 0.63
Fibrosis 0.1 ± 0.32 2.9 ± 0.88* 0.2 ± 0.42 0.3 ± 0.48 2.8 ± 1.32 2.8 ± 0.79
*p < 0.000, significantly higher than sham group; †significantly lower than BDL group. BDL = bile duct ligated group; GL1 = after sham operation
Ganoderma lucidum (GL; 250 mg/kg/d) administered group; GL2 = after sham operation GL (500 mg/kg/d) administered group; GLBDL1 =
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